(Reuters) - Novavax Inc has delivered just a small fraction of the 2 billion COVID-19 shots it plans to send around the world in 2022 and has delayed first-quarter shipments in Europe and lower income countries such as the Philippines, public officials involved in their government's vaccine rollouts told Reuters.
Novavax said it has completed delivery of only around 10 million vaccine doses so far, but is moving as quickly as possible to ship its contracted supplies for this quarter.
